The current valuation score of Lexicon Pharmaceuticals Inc is 9.06, ranking 63 out of 388 in the Biotechnology & Medical Research industry. Its current P/E ratio is -28.57, which is -100.00% below the recent high of 0.00 and -19.61% above the recent low of -34.17.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.